Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1973 1
1975 1
1977 1
1978 1
1983 1
1987 3
1988 3
1989 4
1990 9
1991 4
1992 8
1993 8
1994 10
1995 5
1996 10
1997 10
1998 8
1999 12
2000 10
2001 11
2002 18
2003 15
2004 9
2005 18
2006 7
2007 17
2008 14
2009 15
2010 20
2011 20
2012 25
2013 30
2014 61
2015 80
2016 82
2017 61
2018 64
2019 91
2020 135
2021 177
2022 142
2023 134
2024 62

Text availability

Article attribute

Article type

Publication date

Search Results

1,269 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for japan jm
Search for Napan JM instead (1 results)
Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study.
Shen J, Shen H, Ke L, Chen J, Dang X, Liu B, Hua Y. Shen J, et al. Front Immunol. 2022 Jan 31;13:815575. doi: 10.3389/fimmu.2022.815575. eCollection 2022. Front Immunol. 2022. PMID: 35173728 Free PMC article.
The majority of publications originated from China (n = 893, 54.42%), followed by the United States and Japan. The Sun Yat-sen University contributed the most publications (n = 97, 5.91%). Nakatsura Tetsuya (n = 26) and Llovet JM (n = 366) were ranked first in the t …
The majority of publications originated from China (n = 893, 54.42%), followed by the United States and Japan. The Sun Yat-sen Univer …
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer.
Martinez-Ordoñez A, Duran A, Ruiz-Martinez M, Cid-Diaz T, Zhang X, Han Q, Kinoshita H, Muta Y, Linares JF, Kasashima H, Nakanishi Y, Omar M, Nishimura S, Avila L, Yashiro M, Maeda K, Pannellini T, Pigazzi A, Inghirami G, Marchionni L, Sigal D, Diaz-Meco MT, Moscat J. Martinez-Ordoñez A, et al. Cancer Cell. 2023 Feb 13;41(2):252-271.e9. doi: 10.1016/j.ccell.2022.11.016. Epub 2022 Dec 15. Cancer Cell. 2023. PMID: 36525970 Free PMC article.
Hepatocellular Carcinoma: It Is Time to Focus on Prognosis.
Fowler KJ, Chernyak V, Ronot M, Vilgrain V, Kitao A, Lee JM, Motosugi U, Song B, Jiang H, Sirlin CB, Bashir MR. Fowler KJ, et al. Radiology. 2023 May;307(3):e220884. doi: 10.1148/radiol.220884. Epub 2023 Apr 4. Radiology. 2023. PMID: 37014249 Free PMC article. No abstract available.
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
Amyere M, Revencu N, Helaers R, Pairet E, Baselga E, Cordisco M, Chung W, Dubois J, Lacour JP, Martorell L, Mazereeuw-Hautier J, Pyeritz RE, Amor DJ, Bisdorff A, Blei F, Bombei H, Dompmartin A, Brooks D, Dupont J, González-Enseñat MA, Frieden I, Gérard M, Kvarnung M, Hanson-Kahn AK, Hudgins L, Léauté-Labrèze C, McCuaig C, Metry D, Parent P, Paul C, Petit F, Phan A, Quere I, Salhi A, Turner A, Vabres P, Vicente A, Wargon O, Watanabe S, Weibel L, Wilson A, Willing M, Mulliken JB, Boon LM, Vikkula M. Amyere M, et al. Circulation. 2017 Sep 12;136(11):1037-1048. doi: 10.1161/CIRCULATIONAHA.116.026886. Epub 2017 Jul 7. Circulation. 2017. PMID: 28687708 Free article.
Holography.
Gabor D, Kock WE, Stroke GW. Gabor D, et al. Science. 1971 Jul 2;173(3991):11-23. doi: 10.1126/science.173.3991.11. Science. 1971. PMID: 17747305
Viepsilonnot; in Germany by H. Nassenstein; in Great Britain by J. M. Burch; in Japan by J. Tsujiuchi and T. Tsuruta; and in the Soviet Union by Yu. ...
Viepsilonnot; in Germany by H. Nassenstein; in Great Britain by J. M. Burch; in Japan by J. Tsujiuchi and T. Tsuruta; and in the Sovi …
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
King B, Mostaghimi A, Shimomura Y, Zlotogorski A, Choi GS, Blume-Peytavi U, Passeron T, Holzwarth K, Dutronc Y, McCollam J, Yang FE, Stanley S, Wu WS, Sinclair R. King B, et al. Br J Dermatol. 2023 Feb 10;188(2):218-227. doi: 10.1093/bjd/ljac059. Br J Dermatol. 2023. PMID: 36763878
BACKGROUND: Baricitinib, an oral, selective, reversible Janus kinase (JAK)1/JAK2 inhibitor, is an approved treatment for adults with severe alopecia areata (AA) in the USA, European Union and Japan. OBJECTIVES: To report safety data for baricitinib in patients with severe …
BACKGROUND: Baricitinib, an oral, selective, reversible Janus kinase (JAK)1/JAK2 inhibitor, is an approved treatment for adults with severe …
Fetal and neonatal bilirubin metabolism.
Itoh S, Okada H, Koyano K, Nakamura S, Konishi Y, Iwase T, Kusaka T. Itoh S, et al. Front Pediatr. 2023 Feb 7;10:1002408. doi: 10.3389/fped.2022.1002408. eCollection 2022. Front Pediatr. 2023. PMID: 36824297 Free PMC article. Review.
1,269 results